Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18025763rdf:typepubmed:Citationlld:pubmed
pubmed-article:18025763lifeskim:mentionsumls-concept:C0001688lld:lifeskim
pubmed-article:18025763lifeskim:mentionsumls-concept:C0982327lld:lifeskim
pubmed-article:18025763lifeskim:mentionsumls-concept:C0035525lld:lifeskim
pubmed-article:18025763lifeskim:mentionsumls-concept:C0879626lld:lifeskim
pubmed-article:18025763lifeskim:mentionsumls-concept:C0009429lld:lifeskim
pubmed-article:18025763lifeskim:mentionsumls-concept:C0205191lld:lifeskim
pubmed-article:18025763lifeskim:mentionsumls-concept:C0556895lld:lifeskim
pubmed-article:18025763pubmed:issue22lld:pubmed
pubmed-article:18025763pubmed:dateCreated2007-11-20lld:pubmed
pubmed-article:18025763pubmed:abstractTextThe aim of this study was to elucidate the side effects after combination therapy of peginterferon and ribavirin for Japanese patients with chronic hepatitis C.lld:pubmed
pubmed-article:18025763pubmed:languageenglld:pubmed
pubmed-article:18025763pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18025763pubmed:citationSubsetIMlld:pubmed
pubmed-article:18025763pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18025763pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18025763pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18025763pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18025763pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18025763pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18025763pubmed:statusMEDLINElld:pubmed
pubmed-article:18025763pubmed:issn1349-7235lld:pubmed
pubmed-article:18025763pubmed:authorpubmed-author:KumadaHiromit...lld:pubmed
pubmed-article:18025763pubmed:authorpubmed-author:IkedaKenjiKlld:pubmed
pubmed-article:18025763pubmed:authorpubmed-author:KobayashiMari...lld:pubmed
pubmed-article:18025763pubmed:authorpubmed-author:AraseYasujiYlld:pubmed
pubmed-article:18025763pubmed:authorpubmed-author:SuzukiYoshiyu...lld:pubmed
pubmed-article:18025763pubmed:authorpubmed-author:KobayashiMasa...lld:pubmed
pubmed-article:18025763pubmed:authorpubmed-author:SuzukiFumitak...lld:pubmed
pubmed-article:18025763pubmed:authorpubmed-author:AkutaNorioNlld:pubmed
pubmed-article:18025763pubmed:authorpubmed-author:HosakaTetsuya...lld:pubmed
pubmed-article:18025763pubmed:authorpubmed-author:SezakiHitomiHlld:pubmed
pubmed-article:18025763pubmed:authorpubmed-author:KawamuraYusuk...lld:pubmed
pubmed-article:18025763pubmed:authorpubmed-author:YatsujiHiromi...lld:pubmed
pubmed-article:18025763pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18025763pubmed:volume46lld:pubmed
pubmed-article:18025763pubmed:ownerNLMlld:pubmed
pubmed-article:18025763pubmed:authorsCompleteYlld:pubmed
pubmed-article:18025763pubmed:pagination1827-32lld:pubmed
pubmed-article:18025763pubmed:dateRevised2011-11-17lld:pubmed
pubmed-article:18025763pubmed:meshHeadingpubmed-meshheading:18025763...lld:pubmed
pubmed-article:18025763pubmed:meshHeadingpubmed-meshheading:18025763...lld:pubmed
pubmed-article:18025763pubmed:meshHeadingpubmed-meshheading:18025763...lld:pubmed
pubmed-article:18025763pubmed:meshHeadingpubmed-meshheading:18025763...lld:pubmed
pubmed-article:18025763pubmed:meshHeadingpubmed-meshheading:18025763...lld:pubmed
pubmed-article:18025763pubmed:meshHeadingpubmed-meshheading:18025763...lld:pubmed
pubmed-article:18025763pubmed:meshHeadingpubmed-meshheading:18025763...lld:pubmed
pubmed-article:18025763pubmed:meshHeadingpubmed-meshheading:18025763...lld:pubmed
pubmed-article:18025763pubmed:meshHeadingpubmed-meshheading:18025763...lld:pubmed
pubmed-article:18025763pubmed:meshHeadingpubmed-meshheading:18025763...lld:pubmed
pubmed-article:18025763pubmed:meshHeadingpubmed-meshheading:18025763...lld:pubmed
pubmed-article:18025763pubmed:meshHeadingpubmed-meshheading:18025763...lld:pubmed
pubmed-article:18025763pubmed:meshHeadingpubmed-meshheading:18025763...lld:pubmed
pubmed-article:18025763pubmed:meshHeadingpubmed-meshheading:18025763...lld:pubmed
pubmed-article:18025763pubmed:meshHeadingpubmed-meshheading:18025763...lld:pubmed
pubmed-article:18025763pubmed:meshHeadingpubmed-meshheading:18025763...lld:pubmed
pubmed-article:18025763pubmed:meshHeadingpubmed-meshheading:18025763...lld:pubmed
pubmed-article:18025763pubmed:meshHeadingpubmed-meshheading:18025763...lld:pubmed
pubmed-article:18025763pubmed:meshHeadingpubmed-meshheading:18025763...lld:pubmed
pubmed-article:18025763pubmed:meshHeadingpubmed-meshheading:18025763...lld:pubmed
pubmed-article:18025763pubmed:year2007lld:pubmed
pubmed-article:18025763pubmed:articleTitleSide effects of combination therapy of peginterferon and ribavirin for chronic hepatitis-C.lld:pubmed
pubmed-article:18025763pubmed:affiliationDepartment of Hepatology, Toranomon Hospital, Tokyo. es9y-ars@asahi-net.or.jplld:pubmed
pubmed-article:18025763pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18025763pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:18025763pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:18025763lld:pubmed